Get All Access for $5/mo

Biotech Startup Ahammune Biosciences Raises $5 Million in Series A Funding The fresh funds will be used to support Phase II human clinical trials

By Entrepreneur Staff

You're reading Entrepreneur India, an international franchise of Entrepreneur Media.

Ahammune Biosciences

Ahammune Biosciences, a clinical-stage therapeutics company focused on developing new treatments for skin diseases, has raised USD 5 million in Series A funding. The round was led by pi Ventures, with participation from Capital2B, Colossa Ventures, Bipin Agarwal, Unicornus Maximus LLP, and existing investors like Ideaspring Capital, Kotak Alternate Assets, Legacy Assets LLP, and IAN.

The fresh funds will be used to support Phase II human clinical trials for Ahammune's drug candidate aimed at treating vitiligo, a skin condition that causes white patches. The funding will also help expand the company's patent portfolio and further its research into other immune-related skin diseases.

Founded in 2016 by Dr. Parul Ganju and Dr. Krishnamurthy Natarajan, Ahammune is working to find solutions for chronic skin conditions. Dr. Ganju, the CEO, highlighted the unique approach of their drug, saying, "Unlike existing treatments, our small molecule drug does not cause generalized immunosuppression. It not only stops the spread of white patches but also helps restore skin color."

Commenting on the funding, Dr. Ganju said, "We are grateful for the support from our investors as we move forward with our Phase II trials. This funding allows us to continue our research into immune-mediated skin diseases and develop innovative treatments."

Roopan Aulakh, Managing Director of pi Ventures, expressed confidence in Ahammune's potential,"Their breakthrough drug molecule could treat vitiligo without the side effects seen in current treatments. We are excited to support them in this important journey."

In 2021, the startup raised an undisclosed funding in a round led by Ideaspring Capital and Indian Angel Network with participation of Kotak Private Equity, Dr. Ajith Kamath, and Legacy Assets LLP, along with Dr. Anand Deshpande and Suman Kant Munjal.

Entrepreneur Staff

Entrepreneur Staff

Editor

For more than 30 years, Entrepreneur has set the course for success for millions of entrepreneurs and small business owners. We'll teach you the secrets of the winners and give you exactly what you need to lay the groundwork for success.
Side Hustle

'Hustling Every Day': These Friends Started a Side Hustle With $2,500 Each — It 'Snowballed' to Over $500,000 and Became a Multimillion-Dollar Brand

Paris Emily Nicholson and Saskia Teje Jenkins had a 2020 brainstorm session that led to a lucrative business.

Leadership

Visionaries or Vague Promises? Why Companies Fail Without Leaders Who See Beyond the Bottom Line

Visionary leaders turn bold ideas into lasting impact by building resilience, clarity and future-ready teams.

Marketing

5 Critical Mistakes to Avoid When Giving a Presentation

Are you tired of enduring dull presentations? Over the years, I have compiled a list of common presentation mistakes and how to avoid them. Here are my top five tips.

Science & Technology

Why Businesses Are Relying on Automation to Survive the Labor Crisis

Robots are revolutionizing industries by addressing labor shortages and enhancing efficiency, while businesses navigate challenges like workforce adaptation and high implementation costs.

Business News

Former Steve Jobs Intern Says This Is How He Would Have Approached AI

The former intern is now the CEO of AI and data company DataStax.

Green Entrepreneur®

How Global Business Leaders Can Build a Sustainable Supply Chain

Businesses can build sustainable supply chains by leveraging technology to reduce environmental impact, optimize resources and track emissions while balancing operational efficiency and sustainability goals.